全文获取类型
收费全文 | 27448篇 |
免费 | 1960篇 |
国内免费 | 880篇 |
专业分类
耳鼻咽喉 | 230篇 |
儿科学 | 602篇 |
妇产科学 | 174篇 |
基础医学 | 1989篇 |
口腔科学 | 1087篇 |
临床医学 | 3277篇 |
内科学 | 4648篇 |
皮肤病学 | 187篇 |
神经病学 | 681篇 |
特种医学 | 1680篇 |
外国民族医学 | 3篇 |
外科学 | 7862篇 |
综合类 | 3747篇 |
现状与发展 | 3篇 |
预防医学 | 485篇 |
眼科学 | 1381篇 |
药学 | 1261篇 |
13篇 | |
中国医学 | 430篇 |
肿瘤学 | 548篇 |
出版年
2024年 | 65篇 |
2023年 | 490篇 |
2022年 | 717篇 |
2021年 | 996篇 |
2020年 | 1005篇 |
2019年 | 998篇 |
2018年 | 969篇 |
2017年 | 983篇 |
2016年 | 933篇 |
2015年 | 956篇 |
2014年 | 1704篇 |
2013年 | 1810篇 |
2012年 | 1505篇 |
2011年 | 1707篇 |
2010年 | 1375篇 |
2009年 | 1373篇 |
2008年 | 1460篇 |
2007年 | 1425篇 |
2006年 | 1349篇 |
2005年 | 1211篇 |
2004年 | 1045篇 |
2003年 | 864篇 |
2002年 | 718篇 |
2001年 | 606篇 |
2000年 | 472篇 |
1999年 | 426篇 |
1998年 | 422篇 |
1997年 | 389篇 |
1996年 | 276篇 |
1995年 | 259篇 |
1994年 | 256篇 |
1993年 | 181篇 |
1992年 | 180篇 |
1991年 | 158篇 |
1990年 | 117篇 |
1989年 | 110篇 |
1988年 | 102篇 |
1987年 | 81篇 |
1986年 | 90篇 |
1985年 | 83篇 |
1984年 | 61篇 |
1983年 | 39篇 |
1982年 | 65篇 |
1981年 | 57篇 |
1980年 | 48篇 |
1979年 | 44篇 |
1978年 | 33篇 |
1977年 | 24篇 |
1976年 | 22篇 |
1975年 | 12篇 |
排序方式: 共有10000条查询结果,搜索用时 0 毫秒
31.
32.
目的 观察移植静脉粥样化过程,探讨蛋白聚糖(PG)对粥样化改变的影响。 方法 建立兔移植静脉粥样化模型,阴离子蛋白层析柱分离移植静脉蛋白聚糖,定量分析硫酸乙酰肝素蛋白聚糖(HSPG)和硫酸软骨素-硫酸皮肤素蛋白聚糖(CSPG-DSPG)。 结果 普食组术后8周CSPG-DSPG含量较正常静脉明显增加(P<0.05),术后12~20周含量接近正常,术后20周电镜下见泡沫细胞;高脂组术后8~20周CSPG-DSPG含量较正常静脉明显增加(P<0.05),术后4周见泡沫细胞形成,术后20周血管壁出现无组织结构区域。各组HSPG含量无明显差异(P>0.05),但占总PG比例下降。 结论 HSPG对移植静脉粥样化有一定的保护作用,CSPG-DSPG则具有促进作用。 相似文献
33.
肝癌病人血浆和癌组织中血栓调节蛋白的检测 总被引:3,自引:0,他引:3
目的 检测肝癌病人血浆和肝癌组织中血栓调节蛋白 (TM )的表达 ,探讨TM与肝癌临床病理特征的关系。方法 用酶联免疫吸附夹心法检测 45例肝癌和 6例肝良性占位病人手术前后的血浆TM水平 ;用免疫组织化学法检测肝癌及肝良性占位组织中的TM蛋白表达水平。结果 术前肝癌组血浆TM水平 ( 10 .2± 5 .7)ng/mL明显高于肝良性占位组 ( 6.1± 2 .2 )ng/mL和正常人对照组 ( 5 .7± 1.0 )ng/mL ,P <0 .0 5 ;术前TM血浆水平肝癌伴门静脉癌栓组 ( 6.9± 4.5 )ng/mL和多发肝癌结节组 ( 8.1± 4.6)ng/mL明显低于无门静脉癌栓组( 11.4± 5 .6)ng/mL和单发肝癌结节组 ( 11.5± 5 .9)ng/mL ,P <0 .0 5 ;40例肝癌病人肝癌切除术前TM水平( 10 .8± 5 .3 )ng/mL与肝癌切除术后 ( 7.6± 4.2 )ng/mL相比差异显著 ,P <0 .0 5。肝良性占位组术前与术后相比差异无显著性 ,P >0 .0 5。肝癌组织中TM蛋白表达阳性的病人术前血浆TM水平明显高于TM表达阴性者 ,P <0 .0 5 ;而术后血浆TM水平两者则无显著性差异 ,P >0 .0 5。结论 肝癌病人血浆中TM水平升高 ,TM水平的高低与门静脉癌栓的形成有关 相似文献
34.
目的探讨髂静脉多层螺旋CT成像的临床应用价值。方法50例患者行髂静脉多层螺旋CT血管造影,对比剂注射方案为经患侧足背浅静脉以2.5~3.0ml/s注射浓度为150mgI/ml的非离子型对比剂,延迟16~22s后开始扫描。利用多种重建方法进行重建。分析髂静脉的成像质量以及髂静脉疾病的影像特点。结果50例患者均成功完成CT血管造影。其中31例完全阻塞,9例管腔狭窄或见局部充盈缺损,10例完全通畅。图像质量优良率:优24%(12/50),良60%(30/50),差16%(8/50),总体优良率84%(42/50)。结论多层螺旋CT髂静脉成像对诊断静脉疾病有一定的临床价值。 相似文献
35.
36.
Gerald S. Lipshutz Harish Mahanty Sandy Feng Ryutaro Hirose Peter G. Stock Sang-Mo Kang rew M. Posselt Chris E. Freise 《American journal of transplantation》2005,5(2):366-373
With the introduction of more potent immunosuppressive agents, rejection has decreased in simultaneous pancreas/kidney transplant (SPK) recipients. However, as a consequence, opportunistic infections have increased. The purpose of this report is to outline the course of SPK patients who developed polyomavirus-associated nephropathy (PVAN). A retrospective review of 146 consecutive SPK recipients from January 1, 1996 to December 31, 2002 was performed. Immunosuppression, rejection and development of PVAN were reviewed. Nine patients were identified. All received induction with either OKT3 or thymoglobulin. Immunosuppression included tacrolimus/cyclosporine, MMF/azathioprine and sirolimus/prednisone. Two patients were treated for kidney rejection prior to the diagnosis of PVAN. Time to diagnosis was an average of 359.3 days post-transplantation. Immunosuppression was decreased but five ultimately lost function. However, none developed pancreatic abnormalities as demonstrated by normal glucose and amylase. Two underwent renal retransplantation after PVAN diagnosis and both have normal kidney function. PVAN was the leading cause of renal loss in SPK patients in the first 2 years after transplantation and is a serious concern for SPK recipients. The pancreas, however, is spared from evidence of infection, and no pancreatic rejection occurred when immunosuppression was decreased. 相似文献
37.
张美芳 《浙江中医药大学学报》2006,30(6):684-684
探讨引发产褥期深静脉栓塞的危险因素,加强早期观察,实施有效的预防措施,以及产褥期深静脉栓塞病人的护理对策。 相似文献
38.
TETSUO MAEDA UKIHIDE TATEISHI HIROYUKI FUJIMOTO YAE KANAI KAZURO SUGIMURA YASUAKI ARAI 《International journal of urology》2006,13(5):611-612
We report a case of leiomyosarcoma of the renal vein, which is a rare tumor with no more than 30 cases found in the published English language literature. This case demonstrates encasement of the renal artery by the tumor mass, a previously unreported manifestation. The present study could be useful in considering this rare tumor in the differential diagnosis of renal hilar tumors. 相似文献
39.
T Yamagami S Iida T Kato T Hirota T Nishimura 《Journal of Medical Imaging and Radiation Oncology》2006,50(1):75-78
We present a patient with gastric varices complicating portal hypertension caused by liver cirrhosis related to hepatitis C virus. The patient underwent balloon‐occluded retrograde transvenous obliteration. The gastric varices almost completely disappeared, without any sclerotic agent being used, after iatrogenic injury of the gastrorenal shunt at the time of the interventional procedure. 相似文献
40.
Gregg Hadley 《American journal of transplantation》2004,4(7):1026-1032
Infiltration of CD8(+)TCRalphabeta(+) T-effector populations (CD8 effectors) into graft epithelial compartments has long been recognized as a key lesion in progression of clinical renal allograft rejection. While the afferent phase of allograft immunity is increasingly well-defined, the efferent pathways by which donor-reactive CD8-effector populations access and ultimately destroy the graft renal tubules (rejection per se) have received remarkably little attention. This is an important gap in our knowledge of transplantation immunology, because epithelial compartments comprise the functional elements of most commonly transplanted organs including not only kidney, but also liver, lung, pancreas, and intestine. Furthermore, there is increasing evidence that attack of graft epithelial elements by CD8-effector populations not only causes short-term graft dysfunction but is also a major contributor to development of chronic allograft nephropathy and late graft loss, which now represent the salient clinical problems. Recent studies of the T-cell integrin, alpha(E)beta(7) (CD103), have provided insight into the mechanisms that promote interaction of CD8 effectors with graft epithelial compartments. The purpose of this communication is to review the known properties of the CD103 molecule and its postulated role in the efferent phase of renal allograft rejection. 相似文献